99-24609. Notice Pursuant to the National Cooperative Research and Production Act of 1993Inter Company Collaboration for AIDS Drug Development  

  • [Federal Register Volume 64, Number 183 (Wednesday, September 22, 1999)]
    [Notices]
    [Page 51337]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-24609]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Antitrust Division
    
    
    Notice Pursuant to the National Cooperative Research and 
    Production Act of 1993--Inter Company Collaboration for AIDS Drug 
    Development
    
        Notice is hereby given that, on June 29, 1999, pursuant to Section 
    6(a) of the National Cooperative Research and Production Act of 1993, 
    15 U.S.C. Sec. 4310 et seq. (``the Act''), Inter Company Collaboration 
    for AIDS Drug Development (the ``Collaboration'') has filed written 
    notification simultaneously with the Attorney General and the Federal 
    Trade Commission disclosing changes in its membership status. The 
    notifications were filed for the purpose of extending the Act's 
    provisions limiting the recovery of antitrust plaintiffs to actual 
    damages under specified circumstances. Specifically, although no 
    changes have been made in the membership of the Collaboration, 
    Collaboration member Astra AB of Sweden merged with Zeneca Group PLC of 
    the United Kingdom to form AstraZeneca PLC, a United Kingdom public 
    limited company. In addition, Collaboration member Agouron 
    Pharmaceuticals, Inc. of La Jolla, California has become a wholly owned 
    subsidiary of Warner-Lambert Company of Morris Plains, New Jersey.
        No other changes have been made in either the membership or planned 
    activity of the group research project. Membership in this group 
    research project remains open, and Inter Company Collaboration for AIDS 
    Drug Development intends to file additional written notification 
    disclosing all changes in membership.
        On May 27, 1993, Inter Company Collaboration for AIDS Drug 
    Development filed its original notification to Section 6(a) of the Act. 
    The Department of Justice published a notice in the Federal Register 
    pursuant to Section 6(b) of the Act on July 6, 1993 (58 FR 36223).
        The last notification was filed with the Department on November 30, 
    1998. A notice was published in the Federal Register pursuant to 
    Section 6(b) of the Act on January 29, 1999 (64 FR 4707).
    Constance K. Robinson,
    Director of Operations, Antitrust Division.
    [FR Doc. 99-24609 Filed 9-21-99; 8:45 am]
    BILLING CODE 4410-11-M
    
    
    

Document Information

Published:
09/22/1999
Department:
Antitrust Division
Entry Type:
Notice
Document Number:
99-24609
Pages:
51337-51337 (1 pages)
PDF File:
99-24609.pdf